Matthew E Korenberg's Net Worth
$8.07 Million
Who is Matthew E Korenberg?
Matthew E Korenberg has an estimated net worth of $8.07 Million. This is based on reported shares across multiple companies, which include LIGAND PHARMACEUTICALS INC, and Qualigen Therapeutics, Inc..
SEC CIK
Matthew E Korenberg's CIK is 0001649903
Past Insider Trading and Trends
2022 was Matthew E Korenberg's most active year for acquiring shares with 8 total transactions. Matthew E Korenberg's most active month to acquire stocks was the month of May. 2022 was Matthew E Korenberg's most active year for disposing of shares, totalling 2 transactions. Matthew E Korenberg's most active month to dispose stocks was the month of November. 2023 saw Matthew E Korenberg paying a total of $21,349.28 for 34,073 shares, this is the most they've acquired in one year. In 2022 Matthew E Korenberg cashed out on 7,452 shares for a total of $517,742.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $74.72
PRESIDENT & CHIEF OPERATING
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.12% | 14.42K |
—
|
—
| 103.86K |
Feb 27
| |||
Form 4
| -5.07% | -4.78K |
$74.65 | -$356,677.70 | 89.44K |
Feb 15
| |||
Form 4
| -3.00% | -2.92K |
$72.31 | -$210,928.27 | 94.22K |
Jan 2
| |||
Form 4
| -2.00% | -1.98K |
$59.61 | -$118,266.24 | 97.14K |
Dec 5
| |||
Form 4
| +0.38% | 376 |
$56.78 | $21,349.28 | 99.12K |
Jun 30
| |||
Form 4
| +10.11% | 9.07K |
—
|
—
| 98.75K |
Feb 23
| |||
Form 4
| -3.12% | -2.89K |
$72.98 | -$210,912.20 | 89.68K |
Feb 15
| |||
Form 4
| -4.00% | -3.86K |
$66.29 | -$255,813.11 | 92.57K |
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| +16.98% | 14K |
—
|
—
| 96.43K |
Dec 13
| |||
Form 4
| -4.18% | -3.59K |
$72.90 | -$261,929.70 | 82.43K |
Nov 30
| |||
Form 4
| +47.53% | 27.71K |
—
|
—
| 86.02K |
Nov 1
| |||
Form 4
| +0.31% | 164 |
$75.84 | $12,437.27 | 52.53K |
Jun 30
| |||
Form 4
| +18.20% | 8.06K |
—
|
—
| 52.37K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Qualigen Therapeutics, Inc. (QLGN) Snapshot price: $0.5025
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||